Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (61-70 of 347) with videos related to

Pageof 35
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2018
Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial EssayMerle I Ronden, David Palma, Ben J Slotman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Radiological changes after stereotactic radiotherapy for stage I lung cancerMax Dahele, David Palma, Frank Lagerwaard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2018
Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017Suresh Senan, Chad G Rusthoven, Ben J Slotman, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2015
High-dose conventional thoracic re-irradiation for lung cancer: updated resultsShyama Tetar, Max Dahele, Gwendolyn Griffioen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 2012
An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilizationMax Dahele, Wilko Verbakel, Johan Cuijpers, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Incorporating lung tumor mobility in radiotherapy planningSuresh Senan, Frank J Lagerwaard, Margriet R J Nijssen-Visser
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?Chad G Rusthoven, David A Palma, Suresh Senan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2004
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancerSuresh Senan, Dirk De Ruysscher, Philippe Giraud, et al.
Clinical Lung Cancer|May 16, 2009
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histologyEverett E Vokes, Suresh Senan, Joseph A Treat, et al.
The Lancet. Oncology|August 8, 2015
Surgery versus SABR for resectable non-small-cell lung cancer - Authors' replyJoe Y Chang, Suresh Senan, Egbert F Smit, et al.
Pageof 35

Showing results (61-70 of 347) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2018
Brief Report on Radiological Changes following Stereotactic Ablative Radiotherapy (SABR) for Early-Stage Lung Tumors: A Pictorial EssayMerle I Ronden, David Palma, Ben J Slotman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Radiological changes after stereotactic radiotherapy for stage I lung cancerMax Dahele, David Palma, Frank Lagerwaard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2018
Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017Suresh Senan, Chad G Rusthoven, Ben J Slotman, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2015
High-dose conventional thoracic re-irradiation for lung cancer: updated resultsShyama Tetar, Max Dahele, Gwendolyn Griffioen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 2012
An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilizationMax Dahele, Wilko Verbakel, Johan Cuijpers, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Incorporating lung tumor mobility in radiotherapy planningSuresh Senan, Frank J Lagerwaard, Margriet R J Nijssen-Visser
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?Chad G Rusthoven, David A Palma, Suresh Senan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2004
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancerSuresh Senan, Dirk De Ruysscher, Philippe Giraud, et al.
Clinical Lung Cancer|May 16, 2009
PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histologyEverett E Vokes, Suresh Senan, Joseph A Treat, et al.
The Lancet. Oncology|August 8, 2015
Surgery versus SABR for resectable non-small-cell lung cancer - Authors' replyJoe Y Chang, Suresh Senan, Egbert F Smit, et al.
Pageof 35